Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HSP90AB1 | P08238 | 2/20 | 0.54 |
| ▸ | HSP90AA1 | P07900 | 7/20 | 0.43 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.31 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.31 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.31 |
| ▸ | NPC1 | O15118 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5864484 | 0.83 | HSP90AB1 (0.50) | HSP90AB1HSP90AA1POLB | |
| SCHEMBL5864575 | 0.83 | HSP90AB1 (0.50) | HSP90AB1HSP90AA1POLB | |
| SCHEMBL9350626 | 0.81 | HSP90AB1 (0.52) | HSP90AB1HSP90AA1POLBABCB1ADORA2A | |
| SCHEMBL5864553 | 0.81 | HSP90AB1 (0.52) | HSP90AB1HSP90AA1POLBKDM4EMAPT | |
| SCHEMBL23523689 | 0.80 | HSP90AB1 (0.47) | HSP90AB1HSP90AA1POLBADORA2AADORA1 | |
| SCHEMBL28120669 | 0.78 | HRH4 (0.50) | HSP90AB1HSP90AA1HRH4KDM4EGAA | |
| SCHEMBL20198717 | 0.78 | HRH4 (0.50) | HSP90AB1HSP90AA1HRH4KDM4EGAA | |
| SCHEMBL8071682 | 0.78 | HSP90AB1 (0.71) | HSP90AB1HSP90AA1POLBABCB1ADORA2A | |
| SCHEMBL3631158 | 0.78 | HSP90AB1 (0.71) | HSP90AB1HSP90AA1POLBKDM4EGAA | |
| SCHEMBL27349521 | 0.71 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11388901-B2 | Herbicidal azines | BASF SE (DE) | 2022-07-19 | — | — | US | disclosed |
| US-20210112811-A1 | HERBICIDAL AZINES | BASF SE (DE) | 2021-04-22 | — | — | US | disclosed |
| US-20210112811-A1 | HERBICIDAL AZINES | BASF SE (DE) | 2021-04-22 | — | — | US | disclosed |
| CN-110325529-A | HERBICIDAL AZINES | 巴斯夫欧洲公司 | 2019-10-11 | — | — | CN | disclosed |
| WO-2018166822-A1 | HERBICIDAL AZINES | BASF SE (DE) | 2018-09-20 | — | — | WO | disclosed |
| US-6919339-B2 | ABCA-1 elevating compounds | CV THEAPEUTICS, INC. (US) | 2005-07-19 | — | — | US | disclosed |
| EP-1341773-A2 | SUBSTITUTED 1,3,5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS | CV THERAPEUTICS, INC. (US) | 2003-09-10 | — | — | EP | disclosed |
| US-20020128266-A1 | ABCA-1 elevating compounds | CV THERAPEUTICS, INC. | 2002-09-12 | — | — | US | disclosed |
| WO-2002046172-A2 | SUBSTITUTED 1, 3, 5-TRIAZINES AND PYRIMIDINES AS ABCA-1 ELEVATING COMPOUNDS AGAINST CORONARY ARTERY DISEASE OR ATHEROSCLEROSIS | CV THERAPEUTICS, INC. (US) | 2002-06-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11388901-B2 | Herbicidal azines | DDT, AOC1, AZI2 | HSP90AB1 1366/4885HSP90AA1 1252/4885HRH4 919/4885 |
| US-20210112811-A1 | HERBICIDAL AZINES | DDT, AOC1, AZI2 | HSP90AB1 1366/4885HSP90AA1 1252/4885HRH4 919/4885 |
| US-20020128266-A1 | ABCA-1 elevating compounds | ABCD3, ABCE1, ABCB4 | HSP90AB1 1191/4885HSP90AA1 1676/4885HRH4 4305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.